BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: LeBlanc JF, Wiseman D, Lakatos PL, Bessissow T. Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape. World J Gastroenterol 2019; 25(30): 4158-4171 [PMID: 31435170 DOI: 10.3748/wjg.v25.i30.4158]
URL: https://www.wjgnet.com/1007-9327/full/v25/i30/4158.htm
Number Citing Articles
1
Brigida Barberio, Christopher J Black, Edoardo V Savarino, Alexander C Ford. Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-AnalysisJournal of Crohn's and Colitis 2021; 15(5): 733 doi: 10.1093/ecco-jcc/jjaa226
2
S. Sh. Akhmedkhanov, G. H. Abakarova, A. T. Beibalayeva, B. S. Abdullayeva, Z. M. Saidova. Age-related and Gender Aspects of Inflammatory Bowel Diseases in the Republic of DagestanRussian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4): 68 doi: 10.22416/1382-4376-2022-32-4-68-74
3
Nik Sheng Ding, Daniel Tassone, Ibrahim Al Bakir, Kyle Wu, Alexander J Thompson, William R Connell, George Malietzis, Phillip Lung, Siddharth Singh, Chang-ho Ryan Choi, Simon Gabe, John T Jenkins, Ailsa Hart. Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2022; 16(9): 1475 doi: 10.1093/ecco-jcc/jjac041
4
Keiji Matsuda, Kentaro Asako, Yoshihisa Fukushima, Tamuro Hayama, Kurara Hayashi, Yasuyuki Ikehata, Toshiya Miyata, Kensuke Kaneko, Keijiro Nozawa, Hiroki Ochiai. Surgical Treatment for Ulcerative Colitis in the ElderlyNippon Daicho Komonbyo Gakkai Zasshi 2023; 76(10): 598 doi: 10.3862/jcoloproctology.76.598
5
Tarek Hassab, Duncan McKinney, Christopher D. D'Adamo, Shane Svoboda, Mark Katlic, Joshua H. Wolf. Short-Term Outcomes for Restorative and Non-Restorative Proctocolectomy in Older AdultsJournal of Surgical Research 2022; 269: 11 doi: 10.1016/j.jss.2021.07.012
6
Sophie Vieujean, Bénédicte Caron, Vipul Jairath, Athanase Benetos, Silvio Danese, Edouard Louis, Laurent Peyrin-Biroulet. Is it time to include older adults in inflammatory bowel disease trials? A call for actionThe Lancet Healthy Longevity 2022; 3(5): e356 doi: 10.1016/S2666-7568(22)00060-5
7
Jue Lin, Min Zhang, Min Zhi. Clinical characteristics of elderly-onset inflammatory bowel diseaseWorld Chinese Journal of Digestology 2023; 31(3): 98 doi: 10.11569/wcjd.v31.i3.98
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
8
C. Thompson, S. Taleban. Incorporating Frailty in the Treatment Program of Elderly Patients with Gastrointestinal DiseaseCurrent Treatment Options in Gastroenterology 2020; 18(4): 635 doi: 10.1007/s11938-020-00310-1
9
Paula Sousa, Lorenzo Bertani, Cláudio Rodrigues. Management of inflammatory bowel disease in the elderly: A reviewDigestive and Liver Disease 2023; 55(8): 1001 doi: 10.1016/j.dld.2022.12.024
10
Mahmoud H. Mosli, Maha K. Alghamdi, Omar A. Bokhary, Maria A. Alzahrani, Siba Z. Takieddin, Tala A. Galai, Majid A. Alsahafi, Omar I. Saadah. Inflammatory bowel disease in the elderly: A focus on disease characteristics and treatment patternsSaudi Journal of Gastroenterology 2023; 29(4): 212 doi: 10.4103/sjg.sjg_503_22
11
Vithoosharan Sivanathan, Chamara Basnayake, William Connell, Emily Wright, John Nik Ding, Ola Niewadomski, Annalise Stanley, Amy Wilson‐O'Brien, Stephanie Fry, Tamie Samyue, Mark Lust, Emma Flanagan, Alexander J. V. Thompson, Michael A. Kamm. Clinical outcomes amongst elderly patients with inflammatory bowel diseaseInternal Medicine Journal 2023; 53(10): 1866 doi: 10.1111/imj.15928
12
Rajat Garg, Manik Aggarwal, Robert Butler, Jean Paul Achkar, Bret Lashner, Jessica Philpott, Benjamin Cohen, Taha Qazi, Florian Rieder, Miguel Regueiro, Benjamin Click. Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn’s Disease PatientsDigestive Diseases and Sciences 2022; 67(7): 3138 doi: 10.1007/s10620-021-07117-9
13
Lorenzo Bertani, Domenico Tricò, Daniela Pugliese, Giuseppe Privitera, Giuseppe Linsalata, Federico Zanzi, Maria Gloria Mumolo, Brigida Barberio, Fabio Monzani, Santino Marchi, Luisa Guidi, Corrado Blandizzi, Alessandro Armuzzi, Francesco Costa. Serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patientsAlimentary Pharmacology & Therapeutics 2021; 53(2): 273 doi: 10.1111/apt.16167
14
Simon J. Hong, Seymour Katz. Inflammatory Bowel DiseaseClinical Gastroenterology 2021; : 283 doi: 10.1007/978-3-030-81780-0_12
15
Simon J. Hong, Seymour Katz. The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic managementTherapeutic Advances in Gastroenterology 2021; 14: 175628482110233 doi: 10.1177/17562848211023399
16
Badar Hasan, Kanwarpreet Singh Tandon, Rafael Miret, Sikandar Khan, Amir Riaz, Adalberto Gonzalez, Asad Ur Rahman, Roger Charles, Neeraj Narula, Fernando J. Castro. Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancyJournal of Gastroenterology and Hepatology 2022; 37(6): 1016 doi: 10.1111/jgh.15806
17
Rajat Garg, Manik Aggarwal, Abdul Mohammed, Jean Paul Achkar, Bret Lashner, Jessica Philpott, Benjamin Cohen, Taha Qazi, Florian Rieder, Miguel Regueiro, Benjamin Click. Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn’s diseaseIndian Journal of Gastroenterology 2023; 42(5): 718 doi: 10.1007/s12664-023-01391-3
18
Rodrigo Areán-Sanz, Ana Sofía Ore, Carolina Vigna, Giulio Cataldo, Andrew W. Lynch, Thomas E. Cataldo, Evangelos Messaris. Role of Age as a Predictor of Major Complications After Elective Surgery for Ulcerative ColitisThe American Surgeon™ 2023;  doi: 10.1177/00031348231216496
19
Fang Xu, Anne G. Wheaton, Kamil E. Barbour, Yong Liu, Kurt J. Greenlund. Trends and Outcomes of Hip Fracture Hospitalization Among Medicare Beneficiaries with Inflammatory Bowel Disease, 2000–2017Digestive Diseases and Sciences 2021; 66(6): 1818 doi: 10.1007/s10620-020-06476-z
20
Anne Bozon, Stéphane Nancey, Mélanie Serrero, Ludovic Caillo, Cyrielle Gilletta, Alban Benezech, Roman Combes, Guillaume Danan, Sandrine Akouete, Laurence Pages, Jean-François Bourgaux, Guillaume Le Cosquer, Lucile Boivineau, Magdalena Meszaros, Romain Altwegg. Risk of infection in elderly patients with inflammatory bowel disease under biologics: A prospective, multicenter, observational, one-year follow-up comparative studyClinics and Research in Hepatology and Gastroenterology 2023; 47(5): 102107 doi: 10.1016/j.clinre.2023.102107
21
Marco Gentili, Laura Hidalgo‐Garcia, Teresa Vezza, Erika Ricci, Graziella Migliorati, Alba Rodriguez‐Nogales, Carlo Riccardi, Julio Galvez, Simona Ronchetti. A recombinant glucocorticoid‐induced leucine zipper protein ameliorates symptoms of dextran sulfate sodium‐induced colitis by improving intestinal permeabilityThe FASEB Journal 2021; 35(11) doi: 10.1096/fj.202100778RRRR
22
Franz Hartmann, Kerstin Schwarz. Pflege bei chronisch-entzündlichen Darmerkrankungen2023; : 289 doi: 10.1007/978-3-662-64938-1_26
23
Shervin Sharifkashani. Radiopaedia.org2022;  doi: 10.53347/rID-98131
24
Enrique de-Madaria, José J Mira, Irene Carrillo, Waqqas Afif, Daphne Ang, Marina Antelo, Steven Bollipo, Antoni Castells, Prabhleen Chahal, Henriette Heinrich, Joanna K Law, Monique E van Leerdam, Sabela Lens, Rahul Pannala, San Hyoung Park, Atoosa Rabiee, Edoardo V Savarino, Vikesh K Singh, John Vargo, Aline Charabaty, Joost P H Drenth. The present and future of gastroenterology and hepatology: an international SWOT analysis (the GASTROSWOT project)The Lancet Gastroenterology & Hepatology 2022; 7(5): 485 doi: 10.1016/S2468-1253(21)00442-8
25
Simon J. Hong, Jonathan Galati, Seymour Katz. Crohn's Disease of the ElderlyGastroenterology Clinics of North America 2022; 51(2): 425 doi: 10.1016/j.gtc.2021.12.014
26
Paula Miksa, Shane Ryan Apperley. Inflammatory Bowel Disease: Managing Complex PatientsPhysician Assistant Clinics 2021; 6(4): 655 doi: 10.1016/j.cpha.2021.05.009
27
Shumei Mao, Jinpeng Yao, Teng Zhang, Xiang Zhang, Wei Tan, Chengde Li. Bilobalide attenuates lipopolysaccharide‑induced HepG2 cell injury by inhibiting TLR4‑NF‑κB signaling via the PI3K/Akt pathwayExperimental and Therapeutic Medicine 2023; 27(1) doi: 10.3892/etm.2023.12312